Biointaxis
Barcelona · Founded 2019
About Biointaxis
Biointaxis is a genomic treatment and technology development company. The current lead program develops a gene therapy treatment for Friedreich ataxia, a rare, inherited, progressive neurodegenerative disease that typically affects teenagers and young adults. They reestablished the neurological functions in mice models of friedreich ataxia.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.4M
- Last round: Grant (Oct 2024)
- Website: http://biointaxis.com/
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/biointaxis-61061 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.